Our analysis strongly revealed that FTO and ZPR1 variants are associated with FLD, which is consistent with prior studies linking these genes to metabolic traits and NAFLD. This evidence concerns the gene ZPR1 and metabolic dysfunction-associated steatotic liver disease.